- Home
- JL vs CSCI Comparison
JL vs CSCI Comparison
Compare JL & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JL
- CSCI
- Stock Information
- Founded
- JL 1985
- CSCI 1990
- Country
- JL Hong Kong
- CSCI Canada
- Employees
- JL N/A
- CSCI N/A
- Industry
- JL
- CSCI
- Sector
- JL
- CSCI
- Exchange
- JL NYSE
- CSCI NYSE
- Market Cap
- JL 10.0M
- CSCI 10.5M
- IPO Year
- JL 2024
- CSCI 1996
- Fundamental
- Price
- JL $5.32
- CSCI $3.61
- Analyst Decision
- JL
- CSCI
- Analyst Count
- JL 0
- CSCI 0
- Target Price
- JL N/A
- CSCI N/A
- AVG Volume (30 Days)
- JL 23.1K
- CSCI 3.3K
- Earning Date
- JL 07-31-2025
- CSCI 05-13-2025
- Dividend Yield
- JL N/A
- CSCI N/A
- EPS Growth
- JL N/A
- CSCI N/A
- EPS
- JL 0.54
- CSCI N/A
- Revenue
- JL $32,831,195.00
- CSCI $9,030,000.00
- Revenue This Year
- JL N/A
- CSCI N/A
- Revenue Next Year
- JL N/A
- CSCI N/A
- P/E Ratio
- JL $9.75
- CSCI N/A
- Revenue Growth
- JL 7.72
- CSCI 36.51
- 52 Week Low
- JL $2.33
- CSCI $1.96
- 52 Week High
- JL $13.41
- CSCI $7.72
- Technical
- Relative Strength Index (RSI)
- JL 70.32
- CSCI N/A
- Support Level
- JL $5.23
- CSCI N/A
- Resistance Level
- JL $5.47
- CSCI N/A
- Average True Range (ATR)
- JL 0.35
- CSCI 0.00
- MACD
- JL 0.03
- CSCI 0.00
- Stochastic Oscillator
- JL 70.28
- CSCI 0.00
About JL J-LONG GROUP LIMITED
J-Long Group Ltd is an established distributor in Hong Kong of reflective and non-reflective garment trims including, among others, heat transfers, fabrics, woven labels and tapes, sewing badges, piping, zipper pullers and drawcords. It also offers a wide range of apparel solution services to cater to its customers' needs for reflective and non-reflective garment trims, ranging from market trend analysis, product design and development and production to quality control.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.